Icosapent Ethyl Capsule shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting 2026-04-01 · last update 2026-04-01
Manufacturers: Apotex Corp.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Icosapent Ethyl, Capsule, 1 g (NDC 60429-005-12) | Apotex Corp. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 04/01/2026 Updated 04/01/2026 Discontinued 04/01/2026 |
| Icosapent Ethyl, Capsule, 1 g (NDC 61474-9711-1) | Apotex Corp. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 04/01/2026 Updated 04/01/2026 Discontinued 04/01/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)